From Hope to Silence: The Hidden Stories of 128,127 Patients in Discontinued and Unpublished Obesity Trials | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 5, Issue 2, October 2025 PDF (907.41 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2025.456296 | ||
| Abstract | ||
| The growing and ongoing obsession for treating obesity has led to the use of diabetic treatment injections to try and cure this disease. Anti-diabetic drugs (e.g., Liraglutide/Saxenda, Ozempic, Metformin and Mounjaro) have shown promising weight-loss results in clinical settings. Our study analyzes the discontinuation and non-publication of clinical trials concerning the use of diabetes injections (GLP-1 Agonists) in treating obesity. | ||
|
Statistics Article View: 42 PDF Download: 18 |
||
